Clinical Trial Update: A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating AC-101 tablets for moderate to severe active ulcerative colitis, currently recruiting in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AC-101 Tablets (AC-101)

Snippet

Sponsor: Accro Bioscience (Suzhou) Limited | Conditions: Ulcerative Colitis | Phase 1, Phase 2 | Status: RECRUITING